🚀 VC round data is live in beta, check it out!
- Public Comps
- Salus
Salus Valuation Multiples
Discover revenue and EBITDA valuation multiples for Salus and similar public comparables like Gerresheimer, Arjo, Embecta, Paul Hartmann and more.
Salus Overview
About Salus
Salus is a Slovenia-based company engaged in the wholesale and distribution of medical products. It offers medicines, medical devices, medical supplies, dietary supplements, cosmetics to hospitals, pharmacies, and other customers.
Founded
1969
HQ

Employees
413
Website
Sectors
Financials (FY)
EV
$646M
Salus Financials
Salus reported last fiscal year revenue of $812M and EBITDA of $36M.
In the same fiscal year, Salus generated $97M in gross profit, $36M in EBITDA, and $19M in net income.
Salus P&L
In the most recent fiscal year, Salus reported revenue of $812M and EBITDA of $36M.
Salus expects next 12-month revenue of XXX and NTM EBITDA of XXX
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Revenue | — | XXX | $812M | XXX | XXX | XXX |
| Gross Profit | — | XXX | $97M | XXX | XXX | XXX |
| Gross Margin | — | XXX | 12% | XXX | XXX | XXX |
| EBITDA | — | XXX | $36M | XXX | XXX | XXX |
| EBITDA Margin | — | XXX | 4% | XXX | XXX | XXX |
| EBIT Margin | — | XXX | 3% | XXX | XXX | XXX |
| Net Profit | — | XXX | $19M | XXX | XXX | XXX |
| Net Margin | — | XXX | 2% | XXX | XXX | XXX |
| Net Debt | — | — | $1M | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
Salus Stock Performance
Salus has current market cap of $632M, and enterprise value of $646M.
Market Cap Evolution
Salus' stock price is $76.95.
| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $646M | $632M | 0.5% | XXX | XXX | XXX | $2.37 |
Benchmark Trading Valuation Multiples by Industry
Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.
Start Free TrialSalus Valuation Multiples
Salus trades at 0.8x EV/Revenue multiple, and 18.2x EV/EBITDA.
Salus Financial Valuation Multiples
As of April 11, 2026, Salus has market cap of $632M and EV of $646M.
Equity research analysts estimate Salus' 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
Salus has a P/E ratio of 32.5x.
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Market cap (current) | $632M | XXX | $632M | XXX | XXX | XXX |
| EV (current) | $646M | XXX | $646M | XXX | XXX | XXX |
| EV/Revenue | — | XXX | 0.8x | XXX | XXX | XXX |
| EV/EBITDA | — | XXX | 18.2x | XXX | XXX | XXX |
| EV/EBIT | — | XXX | 28.2x | XXX | XXX | XXX |
| EV/Gross Profit | — | XXX | 6.7x | XXX | XXX | XXX |
| P/E | — | XXX | 32.5x | XXX | XXX | XXX |
| EV/FCF | — | XXX | 44.0x | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Verified Salus Valuation Multiples
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.


Salus Margins & Growth Rates
Salus' revenue in the last fiscal year grew by 7%.
Salus' revenue per employee in the last FY averaged $2.0M, while opex per employee averaged $0.2M for the same period.
Salus Operational Valuation Multiples
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Revenue Growth | — | XXX | 7% | XXX | XXX | XXX |
| EBITDA Margin | — | XXX | 4% | XXX | XXX | XXX |
| EBITDA Growth | — | XXX | 19% | XXX | XXX | XXX |
| Revenue per Employee | — | XXX | $2.0M | XXX | XXX | XXX |
| Opex per Employee | — | XXX | $0.2M | XXX | XXX | XXX |
| S&M Expenses to Revenue | — | XXX | 6% | XXX | XXX | XXX |
| G&A Expenses to Revenue | — | XXX | 3% | XXX | XXX | XXX |
| Opex to Revenue | — | XXX | 9% | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Salus Public Comps
See public comps and valuation multiples for other Medical Supplies comps.
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| LTM | 2026E | 2027E | LTM | 2026E | 2027E | |
| Gerresheimer | XXX | XXX | XXX | XXX | XXX | XXX |
| Arjo | XXX | XXX | XXX | XXX | XXX | XXX |
| Embecta | XXX | XXX | XXX | XXX | XXX | XXX |
| Paul Hartmann | XXX | XXX | XXX | XXX | XXX | XXX |
| Cerus | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
Salus M&A Activity
Salus acquired XXX companies to date.
Last acquisition by Salus was on XXXXXXXX, XXXXX. Salus acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX).
Latest Acquisitions by Salus
| Acquired Company | Valuation | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
Get Verified M&A Valuation Multiples
Sign up to see revenue and EBITDA valuation multiples for 150K+ M&A deals.
Start Free TrialSalus Investment Activity
Salus invested in XXX companies to date.
Salus made its latest investment on XXXXXXXX, XXXXX. Salus invested in XXXXXXXX for XXX (EV/Revenue multiple of XXX).
Latest Investments by Salus
| Company | Valuation | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples
Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.
Start Free TrialAbout Salus
| When was Salus founded? | Salus was founded in 1969. |
| Where is Salus headquartered? | Salus is headquartered in Slovenia. |
| How many employees does Salus have? | As of today, Salus has over 413 employees. |
| Is Salus publicly listed? | Yes, Salus is a public company listed on Ljubljana Stock Exchange. |
| What is the stock symbol of Salus? | Salus trades under SALR ticker. |
| When did Salus go public? | Salus went public in 1999. |
| Who are competitors of Salus? | Salus main competitors are Gerresheimer, Arjo, Embecta, Paul Hartmann. |
| What is the current market cap of Salus? | Salus' current market cap is $632M. |
| What is the current revenue of Salus? | Salus' last fiscal year revenue is $812M. |
| What is the current EV/Revenue multiple of Salus? | Current revenue multiple of Salus is 0.8x. |
| Is Salus profitable? | No, Salus is not profitable. |
Start Your
Free Trial Today
Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.